AEON AMEX
AEON Biopharma, Inc.
1W: -11.9%
1M: -64.9%
3M: -75.6%
YTD: -77.1%
1Y: -67.9%
$0.25
-0.01 (-2.42%)
Weekly Expected Move ±23.3%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$3.0M
52W Range0.222-1.45
Volume231,740
Avg Volume1,149,340
Beta0.61
Dividend—
Analyst Ratings
Company Info
CEORobert Bancroft
Employees8
SectorHealthcare
IndustryBiotechnology
IPO Date2023-07-24
Websiteaeonbiopharma.com
5 Park Plaza
Irvine, CA 92614
US
Irvine, CA 92614
US
949-354-6499
About AEON Biopharma, Inc.
AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in developing therapies based on botulinum toxins, aimed at treating various debilitating medical conditions. Among its key investigational products is ABP-450, a 900 kDa botulinum toxin complex, which is being advanced for therapeutic use in conditions such as migraine, cervical dystonia, and gastroparesis. The entity, originally known as ALPHAEON Corporation, adopted the name AEON Biopharma, Inc. in December 2019. Established in 2012, the company maintains its principal operations from Newport Beach, California.
Latest News
AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society
12 Health Care Stocks Moving In Monday's Intraday Session
AEON Biopharma Sets Annual Shareholder Meeting
AEON Biopharma receives additional NYSE American non-compliance notice
AEON Biopharma GAAP EPS of -$3.95
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Thunen Shelley B | A-Award | 222,684 | — | 2026-06-17 |
| PALMISANO ROBERT J | A-Award | 222,684 | — | 2026-06-17 |
| Forth Marc | A-Award | 222,684 | — | 2026-06-17 |
| FISCHER JOST | A-Award | 222,684 | — | 2026-06-17 |
| Carter Eric G | A-Award | 222,684 | — | 2026-06-17 |